| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |